ARTICLE | Distillery Therapeutics
Cancer
November 6, 2018 8:48 PM UTC
Patient sample, cell culture and mouse studies suggest inhibiting PRMT2 could help treat glioblastoma multiforme (GBM). In GBM patients, high tumor levels of PRMT2 were associated with poor survival. ...
BCIQ Company Profiles
BCIQ Target Profiles